Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
3(21%)
Results Posted
45%(5 trials)

Phase Distribution

Ph phase_1
3
21%
Ph early_phase_1
1
7%
Ph phase_2
3
21%
Ph not_applicable
7
50%

Phase Distribution

4

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
3(21.4%)
Phase 2Efficacy & side effects
3(21.4%)
N/ANon-phased studies
7(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(11)

Detailed Status

Completed11
Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (7.1%)
Phase 13 (21.4%)
Phase 23 (21.4%)
N/A7 (50.0%)

Trials by Status

completed1179%
recruiting17%
active_not_recruiting214%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14